chr2-186625505-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002210.5(ITGAV):c.441G>A(p.Glu147Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00149 in 1,614,010 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 18 hom., cov: 31)
Exomes 𝑓: 0.00079 ( 16 hom. )
Consequence
ITGAV
NM_002210.5 synonymous
NM_002210.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.20
Genes affected
ITGAV (HGNC:6150): (integrin subunit alpha V) The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 2-186625505-G-A is Benign according to our data. Variant chr2-186625505-G-A is described in ClinVar as [Benign]. Clinvar id is 787777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.2 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00818 (1246/152290) while in subpopulation AFR AF= 0.028 (1165/41546). AF 95% confidence interval is 0.0267. There are 18 homozygotes in gnomad4. There are 584 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1246 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGAV | NM_002210.5 | c.441G>A | p.Glu147Glu | synonymous_variant | 4/30 | ENST00000261023.8 | NP_002201.2 | |
ITGAV | NM_001145000.3 | c.441G>A | p.Glu147Glu | synonymous_variant | 4/28 | NP_001138472.2 | ||
ITGAV | NM_001144999.3 | c.303G>A | p.Glu101Glu | synonymous_variant | 4/30 | NP_001138471.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00817 AC: 1244AN: 152172Hom.: 18 Cov.: 31
GnomAD3 genomes
AF:
AC:
1244
AN:
152172
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00216 AC: 544AN: 251312Hom.: 4 AF XY: 0.00157 AC XY: 213AN XY: 135818
GnomAD3 exomes
AF:
AC:
544
AN:
251312
Hom.:
AF XY:
AC XY:
213
AN XY:
135818
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000795 AC: 1162AN: 1461720Hom.: 16 Cov.: 31 AF XY: 0.000653 AC XY: 475AN XY: 727168
GnomAD4 exome
AF:
AC:
1162
AN:
1461720
Hom.:
Cov.:
31
AF XY:
AC XY:
475
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00818 AC: 1246AN: 152290Hom.: 18 Cov.: 31 AF XY: 0.00784 AC XY: 584AN XY: 74470
GnomAD4 genome
AF:
AC:
1246
AN:
152290
Hom.:
Cov.:
31
AF XY:
AC XY:
584
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at